ELMD Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio34.81Forward 20.24
EPS (TTM)$1.1766.7% YoY
Profit margin14.1%HEALTHCARE
Market cap$337.2MSmall cap
Valuation
- Forward P/E
- 20.24
- PEG ratio
- 0.35
- P/B
- 6.86
- P/S (TTM)
- 4.70
- EV/EBITDA
- 22.40
Profitability & growth
- ROE (TTM)
- 21.7%
- Operating margin
- 20.3%
- Revenue growth YoY
- 18.4%
- Dividend yield
- —
- Beta
- 0.50
Last earnings
May 12, 2026 · Estimate $0.24 · Reported $0.35
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Electromed Inc
Company profileElectromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung care for patients of all ages in the United States. and internationally. The company is headquartered in New Prague, Minnesota.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- AMEX
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 500 SIXTH AVENUE NW, NEW PRAGUE, MN
- Fiscal year end
- June
- Latest quarter
- Mar 31, 2026
Market cap$337.2M
Shares outstanding$8.3M
52W high$47.40
52W low$18.13
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent